Intelligence · Clinical Pipeline
ENANTA PHARMACEUTICALS Pipeline
All ClinicalTrials.gov programs at ENANTA PHARMACEUTICALS — phase, modality, and trial IDs.
- Programs
- 13
Quick answer
ENANTA PHARMACEUTICALS has 13 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
-
EDP-235
ENANTA PHARMACEUTICALS INC
COVID-19
3 trials -
EDP-305 1 mg
ENANTA PHARMACEUTICALS INC
Primary Biliary Cholangitis
1 trial -
EDP-305 1.5 mg
ENANTA PHARMACEUTICALS INC
Non-Alcoholic Steatohepatitis
1 trial -
EDP-305 Dose 1
ENANTA PHARMACEUTICALS INC
Non-Alcoholic Steatohepatitis
1 trial -
EDP-323 Dose Regimen 1
ENANTA PHARMACEUTICALS INC
RSV Infection
1 trial -
EDP-420 / Duration of Treatment - 3 days
ENANTA PHARMACEUTICALS INC
Community Acquired Pneumonia
1 trial -
EDP-938
ENANTA PHARMACEUTICALS INC
Respiratory Syncytial Virus
1 trial -
EDP-938
ENANTA PHARMACEUTICALS INC
Respiratory Syncytial Virus (RSV)
2 trials -
EDP-938
ENANTA PHARMACEUTICALS INC
RSV Infection
6 trials -
EDP-938
ENANTA PHARMACEUTICALS INC
Respiratory Syncytial Virus Infections
1 trial -
EDP-938 Dose 1
ENANTA PHARMACEUTICALS INC
RSV Infection
1 trial -
EDP-938, EDP-938 Placebo tablets
ENANTA PHARMACEUTICALS INC
Respiratory syncytial virus (RSV)
1 trial -
zelicapavir
ENANTA PHARMACEUTICALS INC
RSV Infection
1 trial
Frequently asked questions
How many pipeline programs does ENANTA PHARMACEUTICALS have?
13 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This hub lists all published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.
Data attribution: Data sources · All pipeline programs